Smaller increase in delta post-ictal suppression in magnetic seizure therapy than electroconvulsive therapy in geriatric patients with severe depression: A multi-case study

2020 ◽  
Vol 131 (6) ◽  
pp. 1219-1220
Author(s):  
Stefan B. Rowny ◽  
Luke Kluisza ◽  
Joan Prudic ◽  
Monica T. Ly ◽  
Chi-Ming Chen ◽  
...  
2021 ◽  
Vol 10 (4) ◽  
pp. 1-9
Author(s):  
Emily Rushton ◽  
Emma Jones ◽  
Diane Roberts

Electroconvulsive therapy is deemed one of the most effective treatments for alleviating symptoms in individuals diagnosed with severe depression, yet it remains one of the most controversial psychiatric treatments in contemporary mental health nursing practice. As such, its use and efficacy continue to be questioned. The following article analyses the case of Albert, a fictional character who represents the presentation of several patients who have received electroconvulsive therapy. The application of electroconvulsive therapy is evaluated, by referring to the most recent policy and national guidelines. Despite the associated stigma, electroconvulsive therapy can save lives, as portrayed by Albert. However, further research is required and updated guidance from National Institute for Health and Care Excellence is needed, specifically with regards to maintenance and relapse prevention. It is important to be aware of the implications of side effects, just as with other interventions. Overall, this article highlights the importance of safe, recovery-focused and person-centred care.


Author(s):  
Jeledan Tagreed Malik

It has been said before that “No one forgives with more grace and love than a child”. And also no one can compete the child with his outstanding memory which can’t forget deep injuries during childhood, especially when these multiple abuses come from his/her parents and other relatives. Being physically abused, emotionally abused, and neglected from her biological parents and sexually abused from one of her relatives, this 25 years old female, who is a student in the university, suffers from severe depression and very low level of self-esteem. The current research aims at decreasing the client’s depression and improving her self-esteem through case study techniques, assessing her needs, fears, deep feelings and behavior using a variety of methods, including projective tests, life history, interviews and direct observation of her behavior. The researcher will attempt to help this female using the techniques of the “Forgiveness Therapy” which is described by a number of clinicians and researchers as a promising approach to anger-reduction, depression healing and the restoration of general emotional and mental health. Key words: Forgiveness Therapy, depression, self-esteem, child abuse, physical abuse, emotional abuse, neglect, sexual abuse, childhood, case study, clinical psychology.


2021 ◽  
Vol 14 (2) ◽  
pp. e238922
Author(s):  
Geert Schurgers ◽  
Baer M G Arts ◽  
Alida A Postma ◽  
Anna de Kort

Cerebral amyloid angiopathy (CAA) is a condition characterised by accumulation of amyloid beta protein (Aβ) in the wall of cerebral blood vessels which increases the risk of intracranial haemorrhage and contributes to cognitive impairment. We describe the case of a man around the age of 70 with ‘probable’ CAA according to the modified Boston criteria and severe depression whose depression was treated successfully with electroconvulsive therapy (ECT). To the best of our knowledge, there are no earlier published reports of ECT in a patient with CAA. We briefly discuss possible safety measures for these patients, the impact of ECT on cognition in CAA and a possible influence of ECT on Aβ clearance.


2020 ◽  
Vol 2 (2) ◽  
pp. 109-120
Author(s):  
Sayuri Asnani

This study aims to find the effectiveness of coloring art therapy against depression in a teenage girl in Yogyakarta. The hypothesis in this study is that there is a difference in the level of depression of the research subject before and after being given coloring art therapy. The level of depression after coloring art therapy was lower than before coloring art therapy. The sample in this study was a 13-year-old girl in Yogyakarta who had a history of being away from her parents and experienced moderate-severe depression. Coloring art therapy is given individually, twice, using drawing art media and markers. The subject’s depression level was measured using the Beck Depression Inventory (BDI) II scale from initial to final measurements. This study used one research subject with a single one-shot case study pre-experimental design. The data were analyzed by using visual inspection and qualitative analysis. The results of this study indicate that coloring art therapy is effective in reducing depression in young women.Abstrak. Penelitian ini bertujuan untuk mengetahui efektivitas terapi seni mewarnai terhadap depresi pada remaja putri di Yogyakarta. Hipotesis dalam penelitian ini adalah ada perbedaan tingkat depresi subjek antara sebelum diberikan terapi seni mewarnai dengan setelah terapi seni mewarnai. Tingkat depresi setelah terapi seni mewarnai lebih rendah dibanding sebelum terapi seni mewarnai.  Sampel dalam penelitian ini adalah remaja putri di Yogyakarta yang berusia 13 tahun, memiliki riwayat pernah berjauhan dari orangtua dan mengalami depresi sedang-berat. Terapi seni mewarnai ini diberikan secara individual, dua kali, menggunakan media seni gambar dan spidol. Depresi subjek diukur dengan menggunakan skala Beck Depression Inventory (BDI) II dari pengukuran awal sampai akhir. Penelitian ini menggunakan 1 subjek penelitian dengan desain pre-eksperimen single one shot case study. Data analisis dengan inspeksi visual dan analisa kualitatif. Hasil penelitian ini menunjukkan bahwa terapi seni mewarnai efektif dalam menurunkan depresi pada remaja putri.


2006 ◽  
Vol 8 (2) ◽  
pp. 241-258 ◽  

Until recently, a review of nonpharmacological, somatic treatments of psychiatric disorders would have included only electroconvulsive therapy (ECT). This situation is now changing very substantially. Although ECT remains the only modality in widespread clinical use, several new techniques are under investigation. Their principal indication in the psychiatric context is the treatment of major depression, but other applications are also being studied. All the novel treatments involve brain stimulation, which is achieved by different technological methods. The treatment closest to the threshold of clinical acceptability is transcranial magnetic stimulation (TMS). Although TMS is safe and relatively easy to administer, its efficacy has still to be definitively established. Other modalities, at various stages of research development, include magnetic seizure therapy (MST), deep brain stimulation (DBS), and vagus nerve stimulation (VNS). We briefly review the development and technical aspects of these treatments, their potential role in the treatment of major depression, adverse effects, and putative mechanism of action. As the only one of these treatment modalities that is in widespread clinical use, more extended consideration is given to ECT Although more than half a century has elapsed since ECT was first introduced, it remains the most effective treatment for major depression, with efficacy in patients refractory to antidepressant drugs and an acceptable safety profile. Although they hold considerable promise, the novel brain stimulation techniques reviewed here will be need to be further developed before they achieve clinical acceptability.


2020 ◽  
Vol 34 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Martin Balslev Jørgensen ◽  
Maarten Pieter Rozing ◽  
Charles H Kellner ◽  
Merete Osler

Background: The effects of electroconvulsive therapy are usually estimated from changes in depression scales from studies with relatively small patient samples. Larger patient samples can be achieved from epidemiological registers, which provide information on other social and clinical predictors, results and risks. Aims: To examine whether depression severity predicts the use of electroconvulsive therapy, risk of re-hospitalization, suicidal behaviour and mortality following electroconvulsive therapy in patients with major depression. Methods: A cohort of 92,895 patients diagnosed with single or recurrent depression between 2005 and 2016 in the Danish National Patient Registry was followed for electroconvulsive therapy and adverse outcomes. Associations between electroconvulsive therapy and outcomes were analysed using Cox regression. Results: A total of 5004 (5.4%) patients were treated with electroconvulsive therapy. Depression severity was the strongest predictor of electroconvulsive therapy. Electroconvulsive therapy was used more frequently above age 70, in those better educated or married, whereas comorbid alcohol abuse or history of prior stroke at study entry were associated with lower rates. Electroconvulsive therapy was associated with lower mortality. The adjusted hazard ratio for the association between electroconvulsive therapy and suicide in patients with mild depression was 6.99 (3.30–14.43), whereas it was 1.10 (0.55–2.20) in those with severe depression and psychotic symptoms. A similar pattern was seen for emergency contacts and attempted suicide. Conclusions: Electroconvulsive therapy was associated with lower all-cause mortality and the relative risk for re-hospitalization and attempted and committed suicide was lowest in patients with the most severe depression. Electroconvulsive therapy is an important treatment, with significant public health benefits, for patients with severe depression.


2016 ◽  
Vol 33 (S1) ◽  
pp. s262-s263
Author(s):  
J. Silva ◽  
J. Mota ◽  
P. Azevedo

IntroductionElectroconvulsive therapy is currently used in the management of severe depression, long-term mania and catatonia. Regarding schizophrenia-related psychosis ECT is also an option, but the indication is restrictive to severe cases, drug intolerance or resistant ones. Lack of evidence of cost-effectiveness compared to clozapine, and side effects of ECT techniques before 2003, influenced NICE guidance to not recommend ECT in schizophrenia, but modern ECT machines and procedures are subsequent to 2003. ECT is often performed when clozapine fails to respond in monotherapy or if there is intolerance to antipsychotic side effects. ECT in combination with clozapine seems to have significant results allowing the patients to achieve rapid control of psychotic symptoms with fewer side effects, comparing with antipsychotics-association strategies.ObjectivesTo summarized the latest literature about this field and to present recent data from the Electrovulsivetherapy Unit, in Hospital de Magalhães Lemos, Portugal.AimTo explore and critically review the controversies of electroconvulsive therapy in the management of drug-resistant schizophrenia.MethodsRetrospective data of an Electroconvulsive Therapy Unit during 2006–2015 was review.Results198 ECT treatments in schizophrenic patients were performed in our unit, during 2006–2007, in a total of 647 ECT (30,6%). In 2014–2015, 945 schizophrenic patients received ECT treatment, in a total of 2149 performed ECT (43,9%).ConclusionsAlthough guidelines are crucial for the uniform practice of medicine, sometimes is important to be critical about them. The use of ECT in schizophrenia is safe and effective and further research is needed to continue to support this treatment.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document